London-based health tech company Inflow has secured $11 million in a Series A funding round, bringing its total funding to $14 million since its founding in 2020. The company plans to use the new investment to expand its workforce and further develop its ADHD management app, which helps people develop self-management skills and improve daily functioning.
The Inflow platform is built on cognitive behavioral therapy (CBT) principles, offering practical strategies for time management, organization, focus, and emotional regulation. What sets the ADHD management app apart is its blend of structured CBT-based lessons and interactive tools designed specifically for the ADHD community. Users can also take part in group sessions and join a community led by Inflow coaches, giving them both peer support and professional guidance in one place.
Bridging the Gap in ADHD Care
Inflow was founded by Levi Epstein, Seb Isaacs, and George Sachs in response to widespread difficulties in accessing behavioral health services. Many individuals with ADHD face long wait times, high costs, and limited availability of clinicians, creating significant barriers to care. The ADHD management app offers an affordable and accessible alternative, empowering people to learn coping strategies and improve their quality of life even if they can’t immediately access a specialist.
“We want to help our members make significant improvements to their quality of life by giving them the tools to better understand themselves, and implement coping strategies that actually work,” Isaacs said in the company’s release.
With ADHD affecting an estimated 3.5% of the U.S. population, scalable solutions are urgently needed. By focusing on behavioral support, Inflow’s ADHD management app is filling a critical gap and reaching people who may otherwise go untreated.
Investor Confidence in Digital ADHD Solutions
The Series A round was led by Octopus Ventures, a London-based venture capital firm with deep experience in health tech. As part of the deal, Octopus health tech partner Will Gibbs will join Inflow’s board. Additional investors include Hoxton Ventures and Route66 Ventures, along with notable angel investors like Quit Genius co-founders, including CEO Yusuf Sherwani, and DoNotPay CEO Joshua Browder. Their backing signals strong confidence in the long-term potential of the ADHD management app market.
Standing Apart from Telehealth Medication Models
Inflow’s growth comes at a time when telehealth companies offering ADHD treatment through medication management have faced increased scrutiny. The rapid expansion of online prescribing during the pandemic raised concerns about oversight, with companies like TruePill, a virtual pharmacy, facing DEA action over prescriptions of controlled substances.
Unlike these models, Inflow’s ADHD management app does not center around medication. Instead, it emphasizes behavioral therapy, coaching, and community-based support. This distinction not only reduces regulatory risk but also provides a non-prescription, skills-based path for those looking to manage ADHD symptoms in everyday life.
Looking Ahead
With its new funding, Inflow plans to expand its employee headcount and invest in product development to enhance personalization and improve user experience. The company’s long-term vision is to make its ADHD management app the leading digital tool for people worldwide seeking accessible, affordable, and clinically informed ADHD support.
As awareness of ADHD continues to rise, so does the demand for tools that bridge the gap between clinical treatment and daily self-management. By combining CBT-based content with peer accountability and digital convenience, Inflow is positioning itself as a pioneer in the next generation of ADHD care.
For millions of people managing ADHD, this app may be the missing piece—helping users gain confidence, develop coping strategies, and improve their lives outside of traditional clinical settings.
